influenza
viru
influenza
virus
segment
rna
genom
classifi
type
b
c
envelop
glycoprotein
import
target
neutral
antibodi
hemagglutinin
h
initi
infect
bind
cellular
sialic
acid
residu
neuraminidas
n
protein
cleav
newli
synthes
viru
sialic
acid
cell
surfac
allow
spread
viru
adjac
cell
least
antigen
distinct
hemagglutinin
neuraminidas
molecul
influenza
identifi
virus
caus
case
human
diseas
wherea
other
gener
pathogen
aquat
bird
mammal
antigen
variat
h
n
contribut
epidem
natur
influenza
mechan
antigen
drift
due
minor
chang
neutral
epitop
h
result
epidem
necessit
annual
adjust
vaccin
formul
antigen
shift
occur
influenza
virus
exchang
h
n
gene
infect
host
shift
result
influenza
pandem
occur
viru
viru
viru
although
annual
winter
epidem
occur
predict
last
week
one
local
time
onset
sever
highli
variabl
influenza
effici
transmit
via
small
particl
aerosol
gener
cough
sneez
incub
period
facilit
explos
outbreak
close
set
nurs
home
tabl
sinc
b
virus
circul
epidem
infect
caus
greatest
morbid
elderli
popul
older
person
may
rel
resist
sever
diseas
frequent
exposur
prior
impact
influenza
elderli
popul
substanti
greatest
among
person
chronic
diseas
estim
least
influenzarel
hospit
influenzarel
death
unit
state
involv
person
age
year
group
constitut
total
popul
clinic
manifest
influenza
elderli
person
may
differ
classic
influenza
ie
abrupt
fever
myalgia
headach
seen
younger
adult
older
person
lower
frequenc
upper
respiratori
tract
symptom
among
elderli
outpati
cough
fever
acut
onset
ill
posit
predict
valu
contrast
posit
predict
valu
young
adult
studi
older
adult
hospit
document
influenza
cough
nearli
univers
fever
temperatur
seen
fever
alter
mental
statu
may
sign
influenza
pneumonia
older
person
cognit
impair
gastrointestin
complaint
fever
myalgia
help
distinguish
influenza
winter
respiratori
virus
respiratori
syncyti
viru
rsv
tabl
classic
descript
influenzaassoci
lower
respiratori
tract
complic
pandem
louria
et
al
describ
syndrom
radiograph
pneumonia
viral
infect
follow
bacteri
pneumonia
rapidli
progress
diffus
viral
pneumonia
concomit
viralbacteri
pneumonia
today
pure
viral
pneumonia
uncommon
perhap
prior
infect
vaccin
induc
immun
among
older
person
well
rariti
rheumat
heart
diseas
found
highli
vaccin
elderli
person
ie
commun
develop
influenza
season
pneumonia
hospit
patient
influenza
radiograph
infiltr
wherea
equal
percentag
find
consist
congest
heart
failur
diseas
true
incid
secondari
bacteri
pneumonia
influenza
unknown
larg
difficulti
involv
accur
diagnosi
bacteri
infect
recent
studi
bacteri
infect
identifi
hospit
patient
influenza
episod
streptococcu
pneumonia
bacteremia
dual
viralbacteri
infect
sever
viral
infect
alon
evid
higher
rate
intens
care
use
morbid
rsv
rsv
commonli
identifi
caus
viral
pneumonia
older
person
first
isol
chimpanze
cold
subsequ
shown
lead
caus
lower
respiratori
infect
young
children
rsv
rna
viru
belong
paramyxovirida
famili
caus
characterist
syncytia
format
cell
cultur
two
major
antigen
group
rsv
b
caus
annual
winter
epidem
respiratori
diseas
temper
climat
unlik
influenza
viru
rsv
undergo
major
period
antigen
chang
yet
immun
incomplet
reinfect
young
adult
usual
produc
mild
ill
howev
likelihood
sever
diseas
pneumonia
increas
advanc
age
rsv
pneumonia
first
describ
older
adult
howev
appreci
signific
pathogen
outbreak
infect
nurs
home
report
rate
pneumonia
death
rang
respect
composit
studi
indic
nurs
home
resid
develop
rsv
infect
annual
develop
pneumonia
rsv
infect
also
problem
among
elderli
person
live
commun
investig
center
diseas
control
prevent
link
viral
surveil
data
nation
death
databas
estim
rsv
infect
account
death
among
elderli
person
year
studi
adult
cap
rsv
case
commonli
identifi
pathogen
compar
pneumonia
case
influenza
virus
b
case
mycoplasma
pneumonia
found
season
rsv
infect
occur
prospect
monitor
healthi
elderli
person
highrisk
adult
pneumonia
occur
infect
person
addit
rsv
infect
account
winter
discharg
diagnos
pneumonia
clinic
manifest
rsv
pneumonia
difficult
distinguish
viral
bacteri
pneumonia
dyspnea
cough
common
case
uniqu
rsv
infect
typic
rsv
ill
begin
nasal
congest
gradual
progress
wheez
difficulti
breath
compar
influenza
rsv
infect
often
associ
rhinorrhea
sputum
product
wheez
wherea
fever
gastrointestin
complaint
common
influenza
tabl
chest
radiograph
typic
show
patchi
bilater
alveolar
infiltr
interstiti
chang
cultureproven
case
rsv
pneumonia
infiltr
tend
small
illdefin
although
consolid
describ
seventi
percent
patient
rsv
pneumonia
normal
wbc
count
compar
patient
atyp
pneumonia
bacteri
pneumonia
eleven
percent
rsvinfect
patient
may
evid
mix
viralbacteri
infect
human
metapneumoviru
hmpv
hmpv
newli
describ
respiratori
pathogen
identifi
dutch
research
young
children
respiratori
ill
resembl
rsv
bronchiol
hmpv
rna
viru
belong
paramyxovirida
famili
metapneumoviru
genu
worldwid
distribut
univers
infect
age
year
temper
climat
viru
circul
predominantli
winter
month
overlap
season
virus
sever
studi
suggest
may
signific
yeartoyear
variat
incid
rate
hmpv
newli
identifi
viru
clinic
data
still
rel
limit
studi
describ
children
bronchiol
pneumonia
asymptomat
infect
cold
asthma
exacerb
flulik
ill
document
older
children
healthi
young
adult
comprehens
studi
hmpv
caus
cap
among
adult
yet
publish
studi
elderli
subject
highrisk
adult
hmpv
infect
identifi
rtpcr
serolog
test
use
diagnos
impact
greatest
among
cardiopulmonari
diseas
ill
twice
long
healthi
elderli
subject
hospit
person
infiltr
note
chest
radiograph
ill
may
sever
frail
elderli
subject
evidenc
canadian
studi
pneumonia
document
hmpvinfect
nurs
home
resid
clinic
characterist
hmpv
pneumonia
older
adult
appear
distinct
ill
due
winter
respiratori
virus
hmpv
infect
may
somewhat
less
sever
rsv
infect
influenza
lower
rate
mechan
ventil
death
note
one
studi
parainfluenza
virus
piv
piv
paramyxovirus
caus
croup
bronchiti
pneumonia
young
children
piv
type
infect
endem
year
round
infect
due
piv
type
tend
peak
fall
month
infect
recur
throughout
adulthood
account
acut
respiratori
ill
occasion
report
pneumonia
young
adult
elderli
popul
piv
less
well
studi
rsv
pneumonia
report
investig
sweden
found
communitydwel
elderli
person
pneumonia
acut
respiratori
tract
ill
serolog
evid
recent
infect
due
piv
type
prospect
studi
nurs
home
document
piv
infect
respiratori
ill
fatal
case
bronchopneumonia
report
piv
also
implic
precursor
outbreak
invas
pneumococc
diseas
longterm
care
facil
clinic
syndrom
character
fever
rhinorrhea
cough
sore
throat
distinct
coronavirus
coronavirus
rna
virus
deriv
name
crownlik
appear
clubshap
surfac
protein
discov
second
rhinovirus
caus
common
cold
studi
human
ill
limit
inabl
grow
viru
routin
condit
past
decad
strain
infect
diagnos
age
group
serolog
test
recent
new
human
strain
identifi
rtpcr
interest
coronavirus
intensifi
sever
acut
respiratori
syndrom
epidem
spread
quickli
china
proven
due
novel
coronaviru
sarscov
often
occur
late
winter
earli
spring
demonstr
period
healthi
adult
infect
character
lowgrad
fever
malais
nasal
symptom
pneumonia
report
young
children
immunocompromis
patient
elderli
person
coronavirus
identifi
rtpcr
elderli
person
commun
acut
respiratori
ill
recent
dutch
studi
patient
lower
respiratori
tract
symptom
studi
date
report
radiograph
find
thu
frequenc
coronaviru
pneumonia
remain
unknown
rhinovirus
rhinovirus
frequent
caus
common
cold
circul
throughout
year
activ
peak
fall
spring
infect
common
among
person
age
includ
elderli
person
account
respiratori
ill
among
communitydwel
elderli
individu
outbreak
also
document
longterm
care
facil
senior
daycar
center
promin
nasal
congest
cough
constitut
symptom
character
ill
role
rhinovirus
pneumonia
remain
somewhat
controversi
replic
restrict
core
bodi
temperatur
rhinovirus
dismiss
caus
pneumonia
recent
evid
indic
rhinovirus
recov
lower
airway
experiment
challeng
case
pneumonia
describ
young
children
sever
immunocompromis
patient
comprehens
studi
older
adult
cap
use
new
sensit
molecular
techniqu
yet
perform
viral
diagnost
method
includ
cultur
rapid
antigen
detect
rtpcr
serolog
test
avail
sensit
vari
basi
specif
viru
respiratori
secret
appropri
test
includ
nasal
swab
wash
specimen
sputum
specimen
bronchoalveolar
lavag
fluid
sampl
nasal
wash
sampl
prefer
sampl
children
difficult
obtain
frail
cognit
impair
elderli
person
although
slightli
less
sensit
wash
nasal
swab
sampl
accept
altern
viral
cultur
remain
gold
standard
diagnosi
avail
mani
clinic
laboratori
optim
result
requir
prompt
transport
specimen
ice
immedi
inocul
influenza
rel
hardi
grow
well
cultur
day
requir
detect
unsatisfactori
one
must
make
decis
regard
antivir
therapi
cultur
insensit
diagnosi
rsv
infect
rsv
labil
adult
typic
shed
low
titer
piv
rhinovirus
detect
cultur
use
standard
techniqu
hmpv
coronavirus
special
growth
requir
necessit
research
facil
isol
rapid
antigen
test
commerci
avail
influenza
virus
b
rsv
offer
immedi
result
case
done
point
care
diagnosi
influenza
adult
test
offer
sensit
specif
mani
institut
screen
patient
rapid
test
perform
cultur
rapid
test
neg
allow
quick
identif
mani
patient
sacrif
sensit
cultur
given
rate
falseneg
result
rapid
test
patient
influenza
highli
suspect
epidem
isol
treat
antivir
appropri
await
cultur
result
rapid
rsv
antigen
test
use
young
children
shed
high
titer
viru
result
disappoint
adult
compar
serolog
test
rtpcr
sensit
commerci
avail
test
low
rtpcr
sensit
specif
diagnosi
common
respiratori
virus
pivot
defin
adult
diseas
rsv
hmpv
rhinovirus
coronavirus
although
rapid
assay
expens
wide
avail
outsid
major
medic
center
howev
multiplex
rtpcr
hexaplex
prode
commerci
avail
diagnosi
infect
due
multipl
common
respiratori
virus
infect
respiratori
virus
except
sarscov
repres
reinfect
adult
presenc
preexist
antibodi
preclud
singl
serolog
test
detect
igg
antibodi
igm
assay
gener
use
serolog
test
provid
retrospect
diagnosi
increas
specif
antibodi
detect
complement
fixat
eia
rhinoviru
serotyp
serolog
test
impract
diagnosi
wherea
serolog
test
detect
hmpv
coronaviru
avail
research
set
overlap
clinic
syndrom
diagnosi
viral
pneumonia
requir
laboratori
confirm
particularli
import
influenza
treatment
avail
infectioncontrol
issu
aris
hospit
nurs
home
figur
therefor
winter
month
recommend
screen
rapid
antigen
test
patient
admit
hospit
resid
longterm
care
facil
suspici
clinic
syndrom
influenza
activ
commun
recommend
screen
patient
pneumonia
rapid
test
follow
influenza
cultur
result
rapid
test
neg
full
respiratori
viral
cultur
rtpcr
desir
identifi
viral
pathogen
resourc
limit
test
may
restrict
immunocompromis
sever
ill
patient
use
unproven
therapi
sometim
attempt
retrospect
natur
serolog
test
use
investig
nurs
home
outbreak
respiratori
diseas
rather
individu
patient
care
four
antivir
amantadin
rimantadin
zanamivir
oseltamavir
approv
treatment
influenza
tabl
amantadin
rimantadin
activ
influenza
wherea
zanamivir
oseltamavir
activ
influenza
b
agent
effect
prophylaxi
also
reduc
ill
sever
durat
symptom
viral
shed
given
h
symptom
onset
uncompl
influenza
cn
advers
effect
limit
util
amantadin
elderli
popul
issu
resist
develop
quickli
amantadin
rimantadin
zanamivir
oseltamivir
associ
fewer
advers
effect
although
zanamivir
avoid
patient
chronic
obstruct
pulmonari
diseas
asthma
bronchospasm
benefit
antivir
agent
influenza
pneumonia
unknown
placebocontrol
trial
pneumonia
conduct
although
definit
data
lack
author
feel
reason
administ
antivir
agent
elderli
patient
hospit
influenza
pneumonia
treatment
rsv
pneumonia
elderli
adult
larg
support
antivir
therapi
aerosol
ribavirin
rsvspecif
immunoglobulin
approv
highrisk
infant
control
data
avail
adult
although
gener
use
ribavirin
recommend
use
agent
may
consid
select
case
involv
immunocompromis
patient
anecdot
experi
suggest
adult
undergo
intub
highdos
shortdur
therapi
mgml
h
given
mask
time
day
better
toler
tent
treatment
ribavirin
vitro
activ
piv
hmpv
clinic
data
involv
human
antivir
approv
treatment
coronaviru
rhinoviru
infect
immun
remain
effect
mean
reduc
morbid
mortal
associ
influenza
elderli
popul
current
vaccin
avail
standard
trival
inactiv
kill
viru
vaccin
recent
introduc
live
attenu
viru
vaccin
studi
shown
reduct
influenza
hospit
rate
good
antigen
match
vaccin
circul
strain
studi
nearli
communityliv
elderli
subject
administr
trival
inactiv
viru
vaccin
associ
reduct
rate
death
due
caus
signific
reduct
rate
hospit
pneumonia
influenza
cardiac
diseas
stroke
compar
rate
among
nonimmun
person
contrast
recent
analysi
found
decreas
morbid
mortal
rate
among
older
person
even
vaccin
uptak
increas
suggest
better
influenza
vaccin
still
need
although
live
attenu
viru
vaccin
efficaci
young
children
adult
age
year
vaccin
studi
older
person
current
licens
rsv
vaccin
children
adult
transmiss
influenza
may
occur
via
small
particl
aerosol
thu
respiratori
isol
patient
document
suspect
influenza
period
high
influenza
activ
appropri
hand
wash
also
import
especi
patient
receiv
amantadin
rimantadin
prevent
nosocomi
spread
drugresist
viru
major
respiratori
virus
spread
via
fomit
larg
particl
droplet
therefor
respiratori
isol
requir
summari
virus
account
substanti
portion
case
respiratori
ill
pneumonia
elderli
popul
diagnost
test
continu
improv
new
agent
rel
import
known
agent
may
chang
present
influenza
viru
rsv
mostcommonli
identifi
viral
pathogen
older
adult
viral
pneumonia
clinic
featur
period
peak
activ
overlap
winter
month
laboratori
confirm
influenza
recommend
serious
ill
institution
patient
